Literature DB >> 28612020

Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer.

Julian Walter Holch1,2, Maximilian Demmer1, Charlotte Lamersdorf1, Marlies Michl1,2, Christoph Schulz1,2, Jobst Christian von Einem1,2, Dominik Paul Modest1,2, Volker Heinemann1,2.   

Abstract

BACKGROUND: Few studies report the incidence of metastatic patterns in colorectal cancer. Furthermore, little is known about dynamic aspects of these metastases during the course of disease.
METHODS: This retrospective cohort study involved 385 patients who received anti-tumor treatment at our institution (Department of Medical Oncology, University Hospital Grosshadern, Ludwig-Maximilians-University Munich, Germany) for metastatic colorectal adenocarcinoma between 2007 and 2014. We reviewed all available imaging results of these patients to document the presence and detailed localization of metastases.
RESULTS: Most of the evaluated patients were initially diagnosed with metastases in the liver (70%), followed by the lungs (24%), distant lymph nodes (16%), and peritoneum (15%), besides rare anatomical sites (<5%). Colon and rectal cancer as well as synchronous and metachronous metastases differed with regard to the pattern of individual metastatic sites. The median time to first progressive disease (PD) with new metastases was 12.6 months. The time intervals between first and second as well as second and third PD with new metastases were comparable with 10.5 and 10.8 months, respectively. At initial diagnosis, the mean number of metastatic sites was 1.4 and increased to 2.6 at the third PD with new metastases. For patients with initially one metastatic site, the mean number increased to 2.2.
CONCLUSION: The present analysis provides detailed information on the pattern and evolution of colorectal cancer metastases over time. Thus, it may establish the basis for prospective future research in this field.

Entities:  

Keywords:  Development of metastases; Incidence; Localization; Metachronous metastases; Metastatic colorectal cancer; Synchronous metastases

Year:  2017        PMID: 28612020      PMCID: PMC5465778          DOI: 10.1159/000454687

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  24 in total

1.  Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis.

Authors:  Hyuck Jae Choi; Woong Ju; Seung Kwon Myung; Yeol Kim
Journal:  Cancer Sci       Date:  2010-02-11       Impact factor: 6.716

2.  Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population.

Authors:  S Manfredi; A M Bouvier; C Lepage; C Hatem; V Dancourt; J Faivre
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

3.  Mutational analysis and clinical correlation of metastatic colorectal cancer.

Authors:  Andrea L Russo; Darrell R Borger; Jackie Szymonifka; David P Ryan; Jennifer Y Wo; Lawrence S Blaszkowsky; Eunice L Kwak; Jill N Allen; Raymond C Wadlow; Andrew X Zhu; Janet E Murphy; Jason E Faris; Dora Dias-Santagata; Kevin M Haigis; Leif W Ellisen; Anthony J Iafrate; Theodore S Hong
Journal:  Cancer       Date:  2014-02-05       Impact factor: 6.860

4.  Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.

Authors:  C H Köhne; D Cunningham; F Di Costanzo; B Glimelius; G Blijham; E Aranda; W Scheithauer; P Rougier; M Palmer; J Wils; B Baron; F Pignatti; P Schöffski; S Micheel; H Hecker
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

5.  Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series.

Authors:  A E M van der Pool; R A Damhuis; J N M Ijzermans; J H W de Wilt; A M M Eggermont; R Kranse; C Verhoef
Journal:  Colorectal Dis       Date:  2012-01       Impact factor: 3.788

Review 6.  Impact of somatic mutations on patterns of metastasis in colorectal cancer.

Authors:  Marla Lipsyc; Rona Yaeger
Journal:  J Gastrointest Oncol       Date:  2015-12

7.  Epidemiology and management of liver metastases from colorectal cancer.

Authors:  Sylvain Manfredi; Côme Lepage; Cyril Hatem; Olivier Coatmeur; Jean Faivre; Anne-Marie Bouvier
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

8.  Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.

Authors:  Jelena Urosevic; Xabier Garcia-Albéniz; Evarist Planet; Sebastián Real; María Virtudes Céspedes; Marc Guiu; Esther Fernandez; Anna Bellmunt; Sylwia Gawrzak; Milica Pavlovic; Ramon Mangues; Ignacio Dolado; Francisco M Barriga; Cristina Nadal; Nancy Kemeny; Eduard Batlle; Angel R Nebreda; Roger R Gomis
Journal:  Nat Cell Biol       Date:  2014-06-01       Impact factor: 28.824

9.  Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer.

Authors:  Mi-Jung Kim; Hye Seung Lee; Jee Hyun Kim; Yu Jung Kim; Ji Hyun Kwon; Jeong-Ok Lee; Soo-Mee Bang; Kyoung Un Park; Duck-Woo Kim; Sung-Bum Kang; Jae-Sung Kim; Jong Seok Lee; Keun-Wook Lee
Journal:  BMC Cancer       Date:  2012-08-09       Impact factor: 4.430

10.  BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition.

Authors:  Qinhao Guo; Yan Zhao; Jiejing Chen; Jun Hu; Shuwei Wang; Dongsheng Zhang; Yueming Sun
Journal:  Oncol Lett       Date:  2014-05-19       Impact factor: 2.967

View more
  18 in total

1.  Oligometastases of Gastrointestinal Cancer Origin.

Authors:  Nancy E Kemeny; Beate Rau
Journal:  Visc Med       Date:  2017-02-22

2.  Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease.

Authors:  Holger Rumpold; M Hackl; A Petzer; D Wolf
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-03       Impact factor: 4.322

3.  Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with Survival.

Authors:  Eyal Mor; Dan Assaf; Shachar Laks; Haggai Benvenisti; Gal Schtrechman; David Hazzan; Lior Segev; Ronel Yaka; Einat Shacham-Shmueli; Ofer Margalit; Naama Halpern; Daria Perelson; Monica-Inda Kaufmann; Almog Ben-Yaacov; Aviram Nissan; Mohammad Adileh
Journal:  Ann Surg Oncol       Date:  2021-07-07       Impact factor: 5.344

4.  High expression of TFEB is associated with aggressive clinical features in colorectal cancer.

Authors:  Jing Liang; Xinfeng Jia; Kun Wang; Niankun Zhao
Journal:  Onco Targets Ther       Date:  2018-11-13       Impact factor: 4.147

5.  Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.

Authors:  Mohammad Adileh; Eyal Mor; Arie Ariche; Aviram Nissan; Dan Assaf; Haggai Benvenisti; Shachar Laks; Almog Ben-Yaacov; Gal Schtrechman; David Hazzan; Einat Shacham-Shmueli; Ofer Margalit; Naama Halpern; Dan Aderka; Daria Perelson
Journal:  Ann Surg Oncol       Date:  2020-09-23       Impact factor: 5.344

Review 6.  Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer.

Authors:  Troels Dreier Christensen; Sandra Galinska Jensen; Finn Ole Larsen; Dorte Lisbet Nielsen
Journal:  J Bone Oncol       Date:  2018-09-22       Impact factor: 4.072

7.  TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.

Authors:  Nikhil Chauhan; Mary F Mulcahy; Riad Salem; Al B Benson Iii; Eveline Boucher; Janet Bukovcan; David Cosgrove; Chantal Laframboise; Robert J Lewandowski; Fayaz Master; Bassel El-Rayes; Jonathan R Strosberg; Daniel Y Sze; Ricky A Sharma
Journal:  JMIR Res Protoc       Date:  2019-01-17

Review 8.  Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?

Authors:  Emmanouil Damilakis; Dimitrios Mavroudis; Maria Sfakianaki; John Souglakos
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639

9.  Cancer recurrence times from a branching process model.

Authors:  Stefano Avanzini; Tibor Antal
Journal:  PLoS Comput Biol       Date:  2019-11-21       Impact factor: 4.475

Review 10.  Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology.

Authors:  Loretta László; Anita Kurilla; Tamás Takács; Gyöngyi Kudlik; Kitti Koprivanacz; László Buday; Virag Vas
Journal:  Cells       Date:  2021-03-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.